SHILPA MEDICARE share price has zoomed 10% and is presently trading at Rs 637.5.
Meanwhile, the BSE HEALTHCARE index is at 38,055.6 (up 0.5%).
Among the top gainers in the BSE HEALTHCARE index today are Glenmark Pharma (up 2.5%) and FORTIS HEALTHCARE (up 2.3%).
ASTRAZENECA PHARMA (down 1.8%) and METROPOLIS HEALTHCARE (down 1.8%) are among the top losers today.
Over the last one year, SHILPA MEDICARE has moved up from Rs 288.5 to Rs 637.5, registering a gain of Rs 349.1 (up 121.0%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 38,055.6, registering a gain of 48.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 101.3%), Cadila Healthcare (up 98.6%) and Lupin (up 97.8%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,532.1 (down 0.6%).
The top losers among the BSE Sensex today are HDFC Bank (down 4.1%) and M&M (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.
In the meantime, NSE Nifty is at 24,187.4 (down 0.5%). HDFC Bank and M&M are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 79,532.1, registering a gain of 14,327.1 points (up 22.0%).
SHILPA MEDICARE net profit grew 459.7% YoY to Rs 246 million for the quarter ended March 2024, compared to a loss of Rs 69 million a year ago. Net sales rose 10.7% to Rs 2,917 million during the period as against Rs 2,636 million in January-March 2023.
For the year ended March 2023, SHILPA MEDICARE reported 151.0% decrease in net profit to Rs -309 million compared to net profit of Rs 606 million during FY22. Revenue of the company fell 8.3% to Rs 10,501 million during FY23.
The current Price to earnings ratio of SHILPA MEDICARE, based on rolling 12 month earnings, stands at 169.7.
Equitymaster requests your view! Post a comment on "SHILPA MEDICARE Gains 10%; BSE HEALTHCARE Index Up 0.5%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!